LifeAire for Life Sciences
A Closer Look at the LifeAire System
April 24, 2018 | 11:00am EDT
You may be controlling laboratory air with a combination of HEPA/ULPA filtration, increased ACH and controlled air flow. But is it really enough? Is ISO 5 sufficient?
Based on lessons learned from 15 years of clinical research, we’ll address how we successfully approached removing process variability, leading to significantly improved outcomes for both IVF and life science environments.
Categories and sources of air contamination
Clinical outcome data: pre- and post-ambient air control
Kill vs Capture Model
- Why cytotoxic VOCs and viable particulates should be remediated in the life sciences environment
Innovative methods to address purification
Kathryn C. Worrilow, Ph.D. | CEO & Founder | LifeAire
Dr. Worrilow received her doctorate in Anatomy and Cell Physiology from the University of Virginia School of Medicine and completed her postdoctoral fellowship in Reproductive Physiology and Infertility at the University of Pennsylvania School of Medicine. She has served as the Scientific Director of In Vitro Fertilization Programs for over 20 years and has performed extensive work specific to molecular signaling between the sperm and oocyte, the contribution of the paternal genome to the embryo, and the impact of ambient air on successful human embryogenesis and preimplantation toxicology. Her work, with that of her colleagues, led to the development and design of the LifeAire Systems patented air purification technology and System, Aire~IVF®.